Lantern Pharma Inc (LTRN)

Lantern Pharma Inc stock is traded at $0.532, with a volume of 165,959. It is down -9.31% in the last 24 hours and down -44.22% over the past month. Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.